• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不断发展的临床肿瘤放射治疗:关于正常组织保护和质量保证的问题

Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance.

作者信息

Choi Won Hoon, Cho Jaeho

机构信息

Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea .

出版信息

J Korean Med Sci. 2016 Feb;31 Suppl 1(Suppl 1):S75-87. doi: 10.3346/jkms.2016.31.S1.S75. Epub 2016 Jan 28.

DOI:10.3346/jkms.2016.31.S1.S75
PMID:26908993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4756347/
Abstract

Radiotherapy, which is one of three major cancer treatment methods in modern medicine, has continued to develop for a long period, more than a century. The development of radiotherapy means allowing the administration of higher doses to tumors to improve tumor control rates while minimizing the radiation doses absorbed by surrounding normal tissues through which radiation passes for administration to tumors, thereby reducing or removing the incidence of side effects. Such development of radiotherapy was accomplished by the development of clinical radiation oncology, the development of computers and machine engineering, the introduction of cutting-edge imaging technology, a deepened understanding of biological studies on the effects of radiation on human bodies, and the development of quality assurance (QA) programs in medical physics. The development of radiotherapy over the last two decades has been quite dazzling. Due to continuous improvements in cancer treatment, the average five-year survival rate of cancer patients has been close to 70%. The increases in cancer patients' complete cure rates and survival periods are making patients' quality of life during or after treatment a vitally important issue. Radiotherapy is implemented in approximately 1/3 to 2/3s of all cancer patients; and has improved the quality of life of cancer patients in the present age. Over the last century, as a noninvasive treatment, radiotherapy has unceasingly enhanced complete tumor cure rates and the side effects of radiotherapy have been gradually decreasing, resulting in a tremendous improvement in the quality of life of cancer patients.

摘要

放射治疗是现代医学中三大主要癌症治疗方法之一,在长达一个多世纪的时间里持续发展。放射治疗的发展意味着能够向肿瘤给予更高剂量的辐射,以提高肿瘤控制率,同时将辐射穿过以到达肿瘤的周围正常组织所吸收的辐射剂量降至最低,从而降低或消除副作用的发生率。放射治疗的这种发展是通过临床放射肿瘤学的发展、计算机与机械工程的发展、前沿成像技术的引入、对辐射对人体影响的生物学研究的深入理解以及医学物理中质量保证(QA)计划的发展而实现的。过去二十年放射治疗的发展相当引人注目。由于癌症治疗的不断改进,癌症患者的平均五年生存率已接近70%。癌症患者治愈率和生存期的提高使得患者治疗期间或治疗后的生活质量成为一个至关重要的问题。大约三分之一至三分之二的癌症患者接受放射治疗;放射治疗提高了当代癌症患者的生活质量。在过去的一个世纪里,作为一种非侵入性治疗方法,放射治疗不断提高肿瘤的完全治愈率,且放射治疗的副作用逐渐减少,极大地改善了癌症患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/338aa9870303/jkms-31-S75-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/fb8ae401d3e8/jkms-31-S75-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/1459a3b97040/jkms-31-S75-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/092f4beb1baa/jkms-31-S75-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/5e9e69497987/jkms-31-S75-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/338aa9870303/jkms-31-S75-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/fb8ae401d3e8/jkms-31-S75-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/1459a3b97040/jkms-31-S75-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/092f4beb1baa/jkms-31-S75-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/5e9e69497987/jkms-31-S75-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abab/4756347/338aa9870303/jkms-31-S75-g005.jpg

相似文献

1
Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance.不断发展的临床肿瘤放射治疗:关于正常组织保护和质量保证的问题
J Korean Med Sci. 2016 Feb;31 Suppl 1(Suppl 1):S75-87. doi: 10.3346/jkms.2016.31.S1.S75. Epub 2016 Jan 28.
2
Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges.三维适形放射治疗的实施:前景、机遇与挑战。
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):979-83. doi: 10.1016/0360-3016(95)02060-8.
3
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.
4
Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.针对在0.35-T横向磁场条件下进行的(60)钴强度调制放射治疗的患者特异性质量保证。
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):65-72. doi: 10.1016/j.ijrobp.2014.09.008. Epub 2014 Oct 25.
5
Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.癌症治疗中放射治疗的质量保证:致力于提高患者安全性和护理质量。
Jpn J Clin Oncol. 2008 Nov;38(11):723-9. doi: 10.1093/jjco/hyn112.
6
Recent advances in light ion radiation therapy.轻离子放射治疗的最新进展。
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):603-16. doi: 10.1016/j.ijrobp.2003.09.034.
7
Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".现代基于图像的放射治疗的质量保证需求:来自2007年“放射治疗质量保证:先进技术挑战”跨组织研讨会的建议
Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S2-12. doi: 10.1016/j.ijrobp.2007.08.080.
8
Quality assurance in radiation oncology.放射肿瘤学中的质量保证
J Am Coll Radiol. 2005 Jul;2(7):613-6. doi: 10.1016/j.jacr.2005.02.004.
9
[Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].[放射肿瘤学的最新进展——将放射物理学和分子放射生物学进展融入临床放射治疗实践及其他领域]
Ai Zheng. 2008 Aug;27(8):885-93.
10
New technologies in radiation therapy: ensuring patient safety, radiation safety and regulatory issues in radiation oncology.放射治疗中的新技术:确保放射肿瘤学中的患者安全、辐射安全及监管问题。
Health Phys. 2008 Nov;95(5):658-65. doi: 10.1097/01.HP.0000326334.64242.46.

引用本文的文献

1
Balancing Regeneration and Resistance: Targeting DCLK1 to Mitigate Gastrointestinal Radiation Injury and Oncogenesis.平衡再生与抗性:靶向双皮质素样激酶1以减轻胃肠道辐射损伤和肿瘤发生
Cancers (Basel). 2025 Jun 19;17(12):2050. doi: 10.3390/cancers17122050.
2
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre Experience.侵袭性非霍奇金淋巴瘤患者膈下野调强适形放疗(IFRT)与影像引导立体定向放疗(ISRT)的长期疗效——单中心经验
Cancers (Basel). 2024 Feb 2;16(3):649. doi: 10.3390/cancers16030649.
3
Safety Review of Radiotherapy for Tumor Patients with Implantable Cardiac Pacemaker.

本文引用的文献

1
Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer.无基准点射波刀立体定向放射治疗I期非小细胞肺癌的临床结果
Radiat Oncol J. 2015 Jun;33(2):89-97. doi: 10.3857/roj.2015.33.2.89. Epub 2015 Jun 30.
2
Safety considerations for IMRT: Executive summary.调强放射治疗的安全考量:执行摘要。
Pract Radiat Oncol. 2011 Jul-Sep;1(3):190-5. doi: 10.1016/j.prro.2011.04.008. Epub 2011 Jul 8.
3
Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.
植入式心脏起搏器肿瘤患者放疗的安全性评估
Acta Cardiol Sin. 2023 Nov;39(6):807-816. doi: 10.6515/ACS.202311_39(6).20230828A.
4
Radioprotective Potency of Nanoceria.纳米氧化铈的辐射防护功效。
Curr Radiopharm. 2024;17(2):138-147. doi: 10.2174/0118744710267281231104170435.
5
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience.腹部以下放疗野在淋巴瘤患者中的疗效和毒性:单中心经验。
Radiol Med. 2023 Apr;128(4):492-500. doi: 10.1007/s11547-023-01615-8. Epub 2023 Mar 15.
6
Chrysin Encapsulated Copper Nanoparticles with Low Dose of Gamma Radiation Elicit Tumor Cell Death Through p38 MAPK/NF-κB Pathways.低剂量伽马辐射包载白杨素的铜纳米颗粒通过 p38 MAPK/NF-κB 通路诱导肿瘤细胞死亡。
Biol Trace Elem Res. 2023 Nov;201(11):5278-5297. doi: 10.1007/s12011-023-03596-1. Epub 2023 Mar 11.
7
Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime.在遭受联合剂量辐射的小鼠和人胸腺细胞中差异的分子反应。
Sci Rep. 2022 Feb 24;12(1):3144. doi: 10.1038/s41598-022-07166-8.
8
Difference in dose-volumetric data between the analytical anisotropic algorithm, the dose-to-medium, and the dose-to-water reporting modes of the Acuros XB for lung stereotactic body radiation therapy.用于肺部立体定向体部放射治疗的Acuros XB在分析各向异性算法、介质剂量和水剂量报告模式之间的剂量-体积数据差异。
J Appl Clin Med Phys. 2016 Sep 8;17(5):341-347. doi: 10.1120/jacmp.v17i5.6338.
9
Inhibiting the effect of (90)Sr-(90)Y ophthalmic applicators on rat corneal neovascularization induced by sutures.抑制(90)锶-(90)钇眼用敷贴器对缝线诱导的大鼠角膜新生血管形成的作用。
Int J Ophthalmol. 2016 Sep 18;9(9):1251-4. doi: 10.18240/ijo.2016.09.02. eCollection 2016.
10
Emerging targets for radioprotection and radiosensitization in radiotherapy.放射治疗中放射防护和放射增敏的新兴靶点。
Tumour Biol. 2016 Sep;37(9):11589-11609. doi: 10.1007/s13277-016-5117-8. Epub 2016 Jun 19.
保留海马的全脑放疗联合同步推量放疗治疗肺腺癌多发脑转移:早期反应及剂量学评估
Technol Cancer Res Treat. 2016 Feb;15(1):122-9. doi: 10.1177/1533034614566993. Epub 2015 Jan 18.
4
Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.机构针对患者的调强放射治疗质量保证并不能预测不可接受的计划执行情况。
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1195-201. doi: 10.1016/j.ijrobp.2014.08.334. Epub 2014 Oct 21.
5
A preclinical rodent model of acute radiation-induced lung injury after ablative focal irradiation reflecting clinical stereotactic body radiotherapy.一种模拟临床立体定向体部放射治疗后急性放射性肺损伤的啮齿动物模型。
Radiat Res. 2014 Jul;182(1):83-91. doi: 10.1667/RR13535.1. Epub 2014 Jun 17.
6
Magnetic resonance image guided brachytherapy.磁共振图像引导近距离放射治疗
Semin Radiat Oncol. 2014 Jul;24(3):181-91. doi: 10.1016/j.semradonc.2014.02.007.
7
Radiation biology and radiation protection.放射生物学与辐射防护
Ann ICRP. 2012 Oct-Dec;41(3-4):64-71. doi: 10.1016/j.icrp.2012.06.013. Epub 2012 Aug 22.
8
A review of recent developments in image-guided radiation therapy in cervix cancer.宫颈癌图像引导放射治疗的最新进展综述。
Curr Oncol Rep. 2012 Dec;14(6):519-26. doi: 10.1007/s11912-012-0275-3.
9
Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.调强放疗、近距离放疗和根治性前列腺切除术治疗前列腺癌后的继发癌:根据初始治疗干预的发病率和特定原因生存结果。
BJU Int. 2012 Dec;110(11):1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. Epub 2012 Aug 13.
10
Second malignant neoplasms and cardiovascular disease following radiotherapy.放疗后继发第二恶性肿瘤和心血管疾病。
J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6.